ArticleDiscover oncology2025
Analysis of risk factors associated with recurrence of granulomatous lobular mastitis and establishment of a prediction model.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectivesTo explore the risk factors that are associated to the recurrence of granulomatous lobular mastitis (GLM) after treatment and to develop a nomogram model that can predict the risk of recurrence.
methodsMedical records and follow-up data from GLM patients treated at our facility were retrospectively analyzed. In order to identify independent risk factors for GLM recurrence, the patients were split into groups with and without recurrence using univariate and multivariate logistic regression analyses. A predictive nomogram model was built using these variables, and its performance was evaluated by plotting the calibration curve, receiver operating characteristic (ROC), area under the curve (AUC), and decision curve analysis (DCA) curves.
resultsWe evaluated the data of 287 GLM patients, of which 36 patients (12.5%) experienced recurrence, while the remaining 251 patients (87.5%) were included in the non-recurrence group. The affected side's nipple discharge was detected using multivariate logistic regression, nipple inversion on the affected side, surgical treatment, and younger age as the independent risk factors for recurrence (P < 0.05). The model had an AUC of 0.805 (95% CI: 0.737-0.872), 81.7% sensitivity, and 66.7% specificity. The calibration curve was consistent with the ideal curve, and the DCA indicated good clinical utility of the model.
conclusionIndependent risk factors for GLM recurrence include younger age, surgical treatment, nipple discharge on the affected side, and nipple inversion on the affected side. The nomogram based on these factors demonstrated good predictive value for GLM recurrence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.